Vanda Pharmaceuticals (VNDA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 183,186 | 150,031 | 354,171 | 135,029 | 49,397 |
| Marketable Securities | 306,672 | 339,320 | 147,325 | 331,830 | 405,394 |
| Receivables | 29,272 | 33,621 | 24,513 | 33,512 | 29,352 |
| Inventories | 1,006 | 1,080 | 1,105 | 1,194 | 1,590 |
| TOTAL | $536,572 | $533,504 | $533,707 | $519,292 | $507,106 |
| Non-Current Assets | |||||
| PPE Net | 2,128 | 2,164 | 2,333 | 2,573 | 2,594 |
| Intangibles | 17,428 | 17,808 | 18,186 | 18,565 | 18,944 |
| Other Non-Current Assets | 85,477 | 88,206 | 90,306 | 93,817 | 93,144 |
| TOTAL | $105,033 | $108,178 | $110,825 | $114,955 | $114,682 |
| Total Assets | $641,605 | $641,682 | $644,532 | $634,247 | $621,788 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 32,595 | 31,929 | 35,092 | 45,551 | 50,125 |
| Other current liabilities | 52,242 | 55,468 | 58,702 | 45,885 | 42,498 |
| TOTAL | $84,837 | $87,397 | $93,794 | $91,436 | $92,623 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 13,668 | 14,387 | 14,999 | 15,613 | 13,508 |
| TOTAL | $13,668 | $14,387 | $14,999 | $15,613 | $13,508 |
| Total Liabilities | $98,505 | $101,784 | $108,793 | $107,049 | $106,131 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 57,532 | 57,509 | 57,444 | 56,785 | 56,590 |
| Common Shares | 58 | 57 | 57 | 57 | 57 |
| Retained earnings | -152,992 | -153,129 | -154,649 | -157,901 | -164,762 |
| Other shareholders' equity | -967 | -865 | -255 | -1,193 | -1,485 |
| TOTAL | $543,100 | $539,898 | $535,739 | $527,198 | $515,657 |
| Total Liabilities And Equity | $641,605 | $641,682 | $644,532 | $634,247 | $621,788 |